Erasca (ERAS)
(Delayed Data from NSDQ)
$2.38 USD
+0.02 (0.85%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $2.37 -0.01 (-0.21%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ERAS 2.38 +0.02(0.85%)
Will ERAS be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for ERAS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ERAS
Should You Buy Erasca, Inc. (ERAS) After Golden Cross?
Soft Instrument Orders Likely to Hurt PacBio's (PACB) Q1 Earnings
ERAS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's How Cresco Labs (CRLBF) is Placed Before Q1 Earnings
Should SNDL (SNDL) be in Your Portfolio Ahead of Q1 Earnings?
Should You Buy Hims & Hers Health (HIMS) Ahead of Q1 Earnings?
Other News for ERAS
Erasca to Present at Upcoming Investor Conferences in June
e.l.f. Beauty Posts Upbeat Earnings, Joins Nvidia, LiveRamp Holdings, Borr Drilling And Other Big Stocks Moving Higher On Thursday
Jaguar Health, Altamira Therapeutics, Erasca among healthcare movers
Jaguar Health, Altamira Therapeutics,Erasca among healthcare movers
$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying